GNOLF — Genoil Income Statement
0.000.00%
Last trade - 00:00- $19.60m
- $19.84m
Annual income statement for Genoil, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | R2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | — | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.29 | 3.82 | 1.17 | 1.72 | 3.66 |
| Operating Profit | -3.29 | -3.82 | -1.17 | -1.72 | -3.66 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -3.82 | -4.54 | -2.52 | -3.64 | -4.33 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.82 | -4.54 | -2.52 | -3.64 | -4.33 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.82 | -4.54 | -2.52 | -3.64 | -4.33 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.82 | -4.54 | -2.61 | -3.64 | -4.33 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.007 | -0.008 | -0.004 | -0.005 | -0.004 |